Physician

Pathology

Dr. David A. Wiese, MD

David Wiese is an expert in the field of Pathology. David A. Wiese, MD has written publications. He has 36 publications published with PubMed. The lastest paper is: 'Bleeding jejunal leiomyoma: a new approach.' David Wiese accepts all Medicare patients.

Publications

Tumor size predicts long-term survival in colon cancer: an analysis of the National Cancer Data Base.
The prognostic value of additional malignant lesions detected by magnetic resonance imaging versus mammography.
Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis.
Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.
Intraperitoneal virtual biopsy by fibered optical coherence tomography (OCT) at natural orifice transluminal endoscopic surgery (NOTES).
Bleeding jejunal leiomyoma: a new approach.
Appendiceal endometriosis presenting as massive lower intestinal hemorrhage.
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors.
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer.
Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.
Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial.
Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial.
Detection and prognostic impact of micrometastasis in colorectal cancer.
Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma.
Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging.
Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer.
The use of molecular profiling of early colorectal cancer to predict micrometastases.
Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Sentinel lymph node mapping technique in colon cancer.
Historical review of lymphatic mapping in gastrointestinal malignancies.
Nodal positivity in breast cancer correlated with the number of lesions detected by magnetic resonance imaging versus mammogram.
Comparison of nodal positivity between SLNM vs conventional surgery in colon cancer patients with <12 and ?12 lymph nodes harvested.
Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer--do we need both?
A prospective trial comparing 1% lymphazurin vs 1% methylene blue in sentinel lymph node mapping of gastrointestinal tumors.
A prospective study of false-positive diagnosis of micrometastatic cells in the sentinel lymph nodes in colorectal cancer.
Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence.
Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls.
Lymphazurin 1% versus 99mTc sulfur colloid for lymphatic mapping in colorectal tumors: a comparative analysis.
Ultrastaging of colorectal cancer by sentinel lymph node mapping technique--a multicenter trial.

Schools

Michigan State University
Hurley Med Center
Uc Davis Med Center

Doctors Specialties

Cytopathology
Pathology

Accepted Insurances

Education

University of California Davis
Michigan State University College of Human Medicine

Hospital

McLaren Flint

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1023126042
Last Name Of The Provider	WIESE
First Name Of The Provider	DAVID
View All

Similar Doctors

	Dr. Weimin Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. Julio E. Badin, MD
	Dr. Douglas D. Congdon, DO This Doctor is OpenDoctor Recommended.
	Dr. Terry S. Krznarich, MD This Doctor is OpenDoctor Recommended.
	Dr. Cathy E. Blight, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter S. Ng, MD This Doctor is OpenDoctor Recommended.
	Dr. Ernesto B. Quiachon, MD This Doctor is OpenDoctor Recommended.
	Dr. Aamir Ahsan, MD This Doctor is OpenDoctor Recommended.
	Dr. Qazi S. Azher, MD This Doctor is OpenDoctor Recommended.
	Dr. Krishna J. Shah, MD
	Dr. Nader H. Bassily, MD This Doctor is OpenDoctor Recommended.